The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
Open accessAbstract
The vascular endothelial growth factor (VEGF) family is a novel regulator of endothelial cell proliferation. We assessed the mRNA expression of VEGF, VEGF type C (VEGF-C) and their receptors together with the microvessel density (VD) and microlymphatic vessel density (LVD) in pursuit of their connection and prognostic value in malignant pleural mesothelioma (MPM). We used four human MPM cell lines, 54 MPM tumours and five normal pleural tissues. Expression levels for receptors and ligands were assessed by semiquantitative reverse transcriptase polymerase chain reaction analysis. Microvessels were highlighted by immunohistochemical staining for factor VIII. The discrimination of lymphatics was performed by enzyme-histochemistry for 5'-nucleotidase after adequate inhibition of non-specific activity. The expression levels of VEGF, VEGF-C and VEGFRs were high in all MPM cell lines. The percentages of tumours with higher expression compared to the mean values of normal pleural tissues were 31.5% (17/54) for VEGF, 66.7% (36/54) for VEGF-C, 20.4% (11/54) for fms-like tyrosine kinase (flt)-1, 42.6% (23/54) for kinase insert domain-containing recepter (KDR) and 59.3% (32/54) for flt-4. Significant positive correlations were found between VEGF-C and flt-4, VEGF and KDR, VEGF and flt-1 in tumour tissues. The association between LVD and VEGF-C expression level was especially strong (P< 0.0001, r= 0.63). There were also significant correlations between LVD and flt-4, and VD and VEGF. No correlation, however, was found between LVD and nodal metastasis. VD was a negative prognostic indicator in this study. The associations between VEGFNEGF-C and vessel density suggest that these factors play an important role in angiogenesis and lymphangiogenesis in this tumour, and assessment of vascularity may be a useful prognostic indicator for MPM patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
Relation of neovascularisation to metastasis of non-small-cell lung cancer
Macchiarini, P., Fontanini, G., Squartini, F., Angeletti, C. A., & Hardin, M. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)93217-b · Cited by 764
Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., & Alitalo, K. (1996) · Development · doi:10.1242/dev.122.12.3829 · Cited by 690
Meyer, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.363 · Cited by 509
Oh, S.-J., Jeltsch, M. M., Birkenhäger, R., McCarthy, J. E. G., Weich, H. A., Christ, B., Alitalo, K., & Wilting, J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8639 · Cited by 498
Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., & Wood, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1988 · Cited by 401
Toi, M., Hoshina, S., Takayanagi, T., & Tominaga, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02904.x · Cited by 391
Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D
Yamada, Y., Nezu, J.-I., Shimane, M., & Hirata, Y. (1997) · Genomics · doi:10.1006/geno.1997.4774 · Cited by 300
Molecular Basis of Different Forms of Metachromatic Leukodystrophy
Polten, A., Fluharty, A. L., Fluharty, C. B., Kappler, J., von Figura, K., & Gieselmann, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240104 · Cited by 292
Vascular endothelial grouth facter B, a novel growth facter for endothelial cells
Olffson, B. (1996) · Medical Entomology and Zoology · Cited by 279
佐本, 研. (1995) · Medical Entomology and Zoology · doi:10.11501/3108113 · Cited by 269
Mechanisms of Carcinogenesis and Clinical Features of Asbestos-Associated Cancers
Mossman, B. T., Kamp, D. W., & Weitzman, S. A. (1996) · Cancer Investigation · doi:10.3109/07357909609018904 · Cited by 197
Rusch, V. W. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00508-0 · Cited by 179
Airas, L., Niemelä, J., Salmi, M., Puurunen, T., Smith, D. J., & Jalkanen, S. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.2.421 · Cited by 163
Cloning and characterization of a novel human gene related to vascular endothelial growth factor.Preprint
Grimmond, S. M., Lagercrantz, J., Drinkwater, C. C., Silins, G. U., Townson, S. M., Pollock, P. M., Gotley, D. C., Carson, E., Rakar, S., Nordenskjöld, M., et al. (1996) · Genome Research · doi:10.1101/gr.6.2.124 · Cited by 149
Turner, R. R., Beckstead, J. H., Warnke, R. A., & Wood, G. S. (1987) · American Journal of Clinical Pathology · doi:10.1093/ajcp/87.5.569 · Cited by 143
Wilting, J., Birkenhäger, R., Eichmann, A., Kurz, H., Martiny‐Baron, G., Marmé, D., McCarthy, J. E. G., Christ, B., & Weich, H. A. (1996) · Developmental Biology · doi:10.1006/dbio.1996.9993 · Cited by 142
Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder
Chodak, G. W., Haudenschild, C. C., Gittes, R. F., & Folkman, J. (1980) · Annals of Surgery · doi:10.1097/00000658-198012000-00012 · Cited by 139
Characteristics of nine newly derived mesothelioma cell lines
Pass, H. I., Stevens, E. J., Oie, H. K., Tsokos, M., Abati, A. D., Fetsch, P. A., Mew, D., Pogrebniak, H. W., & Matthews, W. J. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00045-m · Cited by 130
Self-citationEVALUATION OF TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN MALIGNANT MESOTHELIOMA
Kumar‐Singh, S., VERMEULEN, P. B., Weyler, J., Segers, K., Weyn, B., Daele, A. V., Dirix, L. Y., OOSTEROM, A. T. V., & Marck, E. V. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199706)182:2<211::aid-path834>3.0.co;2-d · Cited by 92
VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION AND ANGIOGENESIS IN NONSMALL CELL LUNG CARCINOMAS
Mattern, J., Koomägi, R., & Volm, M. (1995) · International Journal of Oncology · doi:10.3892/ijo.6.5.1059 · Cited by 70
Cited by
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
Zalcman, G., Mazieres, J., Margery, J., Greillier, L., Audigier-Valette, C., Moro-Sibilot, D., Molinier, O., Corre, R., Monnet, I., Gounant, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01238-6 · Cited by 968
Lymphangiogenesis and cancer metastasis
Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E., & Alitalo, K. (2002) · Nature Reviews Cancer · doi:10.1038/nrc863 · Cited by 797
Metadata
- Authors
- Ohta, Y., Shridhar, V, Bright, R. K., Kalemkerian, G. P., Du, W., Carbone, M., Watanabe, Y., & Pass, H. I.
- Venue
- British Journal of Cancer
- Published
- 1999-08-13
- Volume
- 81
- Issue
- 1
- Pages
- 54-61
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2081508876
- Cited by
- 335
- References
- 28
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.